Brookfield, WI (PRWEB) August 30, 2012
Comprising more than 250 clinics with more than 1,100 physicians in 38 states, BHN provides advanced diagnostic testing and therapeutic solutions for a wide range of pelvic health and continence disorders. BHN offers a flexible combination of staffing, software, logistics, data and marketing support services—all of which are designed to improve the operational efficiency and profitability of its client practices. BHN has been evaluating ways to expand its solutions for patients seeking non-surgical treatment options. This search led to a new alliance with InControl Medical’s InTone solution.
“We are excited to partner with InControl Medical,” said John Spivey, President & CEO of Bladder Health Networks. “Our clients are always looking for new advances in surgical and non-surgical solutions. The InTone device represents a new paradigm for allowing patients to take control of their pelvic health care in a meaningful way. We believe BHN is well positioned to help bring this technology to market.”
InTone is a medical device available by prescription, indicated for the treatment of stress incontinence, urge incontinence or mixed (stress and urge) incontinence. InTone combines a daily program of volitional exercises, voice-guided instruction, visual biofeedback and micro-current stimulation to strengthen the muscle tone in the pelvic floor.
After prescribing InTone, the physician customizes the stimulation to ensure proper muscle activation. InTone treatment is then completed in the privacy of the patient’s home, greatly enhancing compliance with pelvic floor training. After two weeks, the physician analyzes data recorded from each session and adjusts InTone based on the quantitative data provided. Most patients experience effective relief in approximately 90 days.
According to the National Association for Continence:
- Two-thirds of women age 30-70 have never discussed bladder health with their doctor.
- On average, women wait 6 1/2 years from the first time they experience symptoms until they obtain a diagnosis for their bladder control problems.
- Two-thirds of individuals who experience loss of bladder control symptoms do not use any treatment or product to manage their incontinence.
“The leadership at InControl Medical shares our passion to help people who are suffering from incontinence. Our alliance will not only help educate patients that ‘leaking isn’t normal,’ but it will provide patients with a great therapeutic tool to help them regain a lifestyle that may have been interrupted by incontinence,” said Spivey.
“This partnership with BHN is a tremendous opportunity for both companies,” said Herschel “Buzz” Peddicord, president of InControl Medical, “and we think it greatly enhances the range of treatment options available to BHN’s physicians and their patients.”